LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 55 filers reported holding LARIMAR THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $359,136 | +18440.8% | 114,740 | -73.2% | 0.00% | -100.0% |
| Q1 2023 | $1,937 | +127.1% | 427,608 | +107.0% | 0.00% | – |
| Q4 2022 | $853 | -99.6% | 206,578 | +228.7% | 0.00% | – |
| Q3 2022 | $201,000 | -92.1% | 62,841 | -75.6% | 0.00% | -100.0% |
| Q2 2021 | $2,532,000 | -51.0% | 257,868 | -27.1% | 0.00% | -50.0% |
| Q1 2021 | $5,168,000 | +555.0% | 353,763 | +859.7% | 0.00% | +300.0% |
| Q4 2020 | $789,000 | +18.5% | 36,862 | -16.0% | 0.00% | 0.0% |
| Q3 2020 | $666,000 | +202.7% | 43,886 | +156.3% | 0.00% | – |
| Q2 2020 | $220,000 | – | 17,121 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,473,366 | $14,345,001 | 3.82% |
| Opaleye Management Inc. | 1,560,000 | $6,442,800 | 2.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $69,967,804 | 1.45% |
| GREAT POINT PARTNERS LLC | 1,273,635 | $5,260,113 | 1.03% |
| DAFNA Capital Management LLC | 473,136 | $1,954,052 | 0.55% |
| COMMODORE CAPITAL LP | 750,000 | $3,098 | 0.47% |
| Cheyne Capital Management (UK) LLP | 63,680 | $262,998 | 0.46% |
| Atlas Venture Advisors, Inc. | 292,184 | $1,206,720 | 0.42% |
| Perceptive Advisors | 2,860,000 | $11,811,800 | 0.33% |
| MANGROVE PARTNERS IM, LLC | 1,292,812 | $5,339,314 | 0.30% |